Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma

被引：2

作者：

Itoh, Shinji ^{[1
]}

Ikeda, Masafumi ^{[2
]}

机构：

[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan

[2] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Japan

来源：

HEPATOBILIARY SURGERY AND NUTRITION | 2022年

关键词：

D O I：

10.21037/hbsn-22-432

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[41] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma [J].

Vithayathil, Mathew ;

D'Alessio, Antonio ;

Weinmann, Arndt ;

Galle, Peter ;

Fulgenzi, Claudia Angela Maria ;

Fessas, Petros ;

Bettinger, Dominik ;

Bengsch, Bertram ;

Vogel, Arndt ;

Balcar, Lorenz ;

Scheiner, Bernhard ;

Muzaffar, Mahvish ;

Amara, Suneetha ;

Muhammed, Ambreen ;

Naqash, Abdul Rafeh ;

Personeni, Nicola ;

Pressiani, Tiziana ;

Cammarota, Antonella ;

Pinter, Matthias ;

Cortellini, Alessio ;

Rimassa, Lorenza ;

Pinato, David J. ;

Sharma, Rohini .

JOURNAL OF HEPATOLOGY, 2022, 77 :S374-S375

[42] Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis [J].

Tada, Toshifumi ;

Kumada, Takashi ;

Hiraoka, Atsushi ;

Hirooka, Masashi ;

Kariyama, Kazuya ;

Tani, Joji ;

Atsukawa, Masanori ;

Takaguchi, Koichi ;

Itobayashi, Ei ;

Fukunishi, Shinya ;

Tsuji, Kunihiko ;

Ishikawa, Toru ;

Tajiri, Kazuto ;

Ochi, Hironori ;

Yasuda, Satoshi ;

Toyoda, Hidenori ;

Ogawa, Chikara ;

Nishimura, Takashi ;

Hatanaka, Takeshi ;

Kakizaki, Satoru ;

Shimada, Noritomo ;

Kawata, Kazuhito ;

Tanaka, Takaaki ;

Ohama, Hideko ;

Nouso, Kazuhiro ;

Morishita, Asahiro ;

Tsutsui, Akemi ;

Nagano, Takuya ;

Itokawa, Norio ;

Okubo, Tomomi ;

Arai, Taeang ;

Imai, Michitaka ;

Naganuma, Atsushi ;

Koizumi, Yohei ;

Nakamura, Shinichiro ;

Joko, Kouji ;

Iijima, Hiroko ;

Hiasa, Yoichi .

CANCER MEDICINE, 2022, 11 (20) :3796-3808

[43] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma [J].

Vithayathil, Mathew ;

D'Alessio, Antonio ;

Fulgenzi, Claudia Angela Maria ;

Nishida, Naoshi ;

Schoenlein, Martin ;

von Felden, Johann ;

Schulze, Kornelius ;

Wege, Henning ;

Saeed, Anwaar ;

Wietharn, Brooke ;

Hildebrand, Hannah ;

Wu, Linda ;

Ang, Celina ;

Marron, Thomas U. ;

Weinmann, Arndt ;

Galle, Peter R. ;

Bettinger, Dominik ;

Bengsch, Bertram ;

Vogel, Arndt ;

Balcar, Lorenz ;

Scheiner, Bernhard ;

Lee, Pei-Chang ;

Huang, Yi-Hsiang ;

Amara, Suneetha ;

Muzaffar, Mahvish ;

Naqash, Abdul Rafeh ;

Cammarota, Antonella ;

Zanuso, Valentina ;

Pressiani, Tiziana ;

Pinter, Matthias ;

Cortellini, Alessio ;

Kudo, Masatoshi ;

Rimassa, Lorenza ;

Pinato, David J. ;

Sharma, Rohini .

HEPATOLOGY INTERNATIONAL, 2023, 17 (04) :904-914

[44] Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy [J].

Maesaka, Kazuki ;

Sakamori, Ryotaro ;

Yamada, Ryoko ;

Tahata, Yuki ;

Imai, Yasuharu ;

Ohkawa, Kazuyoshi ;

Miyazaki, Masanori ;

Mita, Eiji ;

Ito, Toshifumi ;

Hagiwara, Hideki ;

Yakushijin, Takayuki ;

Kodama, Takahiro ;

Hikita, Hayato ;

Tatsumi, Tomohide ;

Takehara, Tetsuo .

HEPATOLOGY RESEARCH, 2022, 52 (03) :298-307

[45] Prognostic Biomarkers for Hepatocellular Carcinoma Patients Treated With Atezolizumab plus Bevacizumab Combination Therapy [J].

Jeng, Long-Bin ;

Yang, Horng-Ren ;

Teng, Chiao-Fang .

CANCER CONTROL, 2025, 32

[46] CHILD-PUGH CLASS DETERMINES THE OUTCOME OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH ATEZOLIZUMAB AND BEVACIZUMAB-A REAL-WORLD EXPERIENCE [J].

Kulkarni, Anand V. ;

Krishna, Vamshi ;

Patodiya, Bharat ;

Shaik, Sameer ;

Khan, Arif ;

Sharma, Mithun ;

Da, Pramod K. ;

Reddy, Nageshwar D. ;

Rao, Padaki Nagaraja .

HEPATOLOGY, 2022, 76 :S1435-S1435

[47] Systemic therapy for Child-Pugh B patients with hepatocellular carcinoma [J].

Mok, Kevin ;

Chen, Olivia ;

Yau, Johnny ;

Chan, Landon L. ;

Chan, Stephen L. .

EXPERT OPINION ON EMERGING DRUGS, 2025, 30 (01) :1-5

[48] A multicenter, phase 2 study of atezolizumab plus bevacizumab (atezo plus bev) combination therapy in patients with unresectable hepatocellular carcinoma (HCC) and Child-Pugh class B cirrhosis: CHALLENGE trial final results. [J].

Ikeda, Masafumi ;

Terashima, Takeshi ;

Yamashita, Tatsuya ;

Okusaka, Takuji ;

Imaoka, Hiroshi ;

Kawaoka, Tomokazu ;

Kobayashi, Satoshi ;

Ogasawara, Sadahisa ;

Hiraoka, Atsushi ;

Nakano, Masahito ;

Nagashima, Fumio ;

Sugimoto, Rie ;

Moriguchi, Michihisa ;

Inaba, Yoshitaka ;

Shinoda, Satoru ;

Ueno, Makoto ;

Kato, Naoya ;

Kudo, Masatoshi ;

Furuse, Junji ;

Nagano, Hiroaki .

JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)

[49] Rechallenge With Lenvatinib After Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma [J].

Komatsu, Shohei ;

Yano, Yoshihiko ;

Kido, Masahiro ;

Kuramitsu, Kaori ;

Gon, Hidetoshi ;

Fukushima, Kenji ;

Urade, Takeshi ;

So, Shinichi ;

Yamamoto, Atsushi ;

Goto, Tadahiro ;

Yanagimoto, Hiroaki ;

Toyama, Hirochika ;

Ueda, Yoshihide ;

Kodama, Yuzo ;

Fukumoto, Takumi .

ANTICANCER RESEARCH, 2022, 42 (11) :5479-5486

[50] Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab [J].

Yano, Shigeki ;

Kawaoka, Tomokazu ;

Johira, Yusuke ;

Miura, Ryoichi ;

Kosaka, Masanari ;

Shirane, Yuki ;

Murakami, Serami ;

Amioka, Kei ;

Naruto, Kensuke ;

Ando, Yuwa ;

Kosaka, Yumi ;

Yamaoka, Kenji ;

Kodama, Kenichiro ;

Uchikawa, Shinsuke ;

Fujino, Hatsue ;

Ohno, Atsushi ;

Nakahara, Takashi ;

Murakami, Eisuke ;

Okamoto, Wataru ;

Yamauchi, Masami ;

Imamura, Michio ;

Mori, Keiichi ;

Arihiro, Kouji ;

Kuroda, Shintaro ;

Kobayashi, Tsuyoshi ;

Ohdan, Hideki ;

Aikata, Hiroshi .

MEDICINE, 2021, 100 (42) :E27576

← 1 2 3 4 5 →